| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/26/2008 | US7417063 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent |
| 08/26/2008 | US7417047 Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation |
| 08/26/2008 | US7417046 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 08/26/2008 | US7417045 Antiinflammatory agents;to treat chemokine mediated diseases; Antitumor agents; autoimmune diseases |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2329230C A process for the manufacture of sulfonylaminocarbonyl triazolinones in the presence of xylene as solvent |
| 08/21/2008 | WO2008101247A2 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity |
| 08/21/2008 | WO2008100867A2 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | WO2008100463A1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | WO2008099794A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | WO2008099145A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 08/21/2008 | WO2008099076A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 08/21/2008 | WO2008099073A1 N, n' -2, 4-dianilinopyrimidines preparation and use thereof as ikk inhibitors preparation and teh pharmacuetical compositions thereof |
| 08/21/2008 | WO2008099022A1 10-sulfonyl-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008099019A1 6-hydroxy-dibenzodiazepinones useful as hepatitis c virus inhibitors |
| 08/21/2008 | WO2008034736A3 Oxindole derivatives as anticancer agents |
| 08/21/2008 | WO2008031550A3 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 08/21/2008 | WO2007139955A3 Triazole compounds that modulate hsp90 activity |
| 08/21/2008 | US20080200687 Preparation of Terazole Derivatives |
| 08/21/2008 | US20080200527 obesity, metabolic syndrome, Type II diabetes, cardiovascular disease, osteoarthritis, cancers; mental disorders; sexual and/or reproductive dysfunctions, epilepsy; 5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid [3-(1H-tetrazol-5-yl)-propyl]-amide |
| 08/21/2008 | US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives |
| 08/21/2008 | US20080200511 Novel Compounds and Methods of Using the Same |
| 08/21/2008 | US20080200509 Utilizing such as 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide against cancer growth |
| 08/21/2008 | US20080200485 of Aurora-2 (Aurora-A) protein kinase; anticancer; 6-(pyrazolylamino)-4-pyrimidine carboxamides; Methyl 2-(4-cyclopropanecarboxamidophenylsulfanyl)-5-amino-6-(5-methylpyrazol-3-ylamino)-4-pyrimidinecarboxylate |
| 08/21/2008 | US20080200476 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 08/21/2008 | US20080200472 urinary incontinence, ulcer, inflammatory bowel disease, addiction, Parkinson's, anxiety, epilepsy, seizures, pruritus, psychosis, cognitive disorder, Huntington's chorea, ALS, retinopathy, migraine, vomiting, dyskinesia, depression; Pyridazinylpiperazine compounds; VR1 Vanilloid Receptor 1 antagonists |
| 08/21/2008 | US20080200469 Phthalazinone derivatives |
| 08/21/2008 | US20080200465 Antipathogenic benzamide compounds |
| 08/21/2008 | US20080200455 1-Aryl- or 1-Alkylsulfonyl-Heterocyclylbenzazoles As 5-Hydroxytryptamine-6 Ligands |
| 08/21/2008 | US20080200445 Heterocyclic aspartyl protease inhibitors |
| 08/21/2008 | US20080199459 Mitotic Kinesin Inhibitors |
| 08/21/2008 | DE102007007751A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 08/21/2008 | CA2679849A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2678382A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 08/21/2008 | CA2678036A1 Functionally selective alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | CA2677678A1 3,4-dihydro-1,4-benzoxazine, 3, 4-dihydro-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists |
| 08/21/2008 | CA2676906A1 Novel inhibitors hepatitis c virus replication |
| 08/21/2008 | CA2676715A1 Piperazine derivatives for treatment of ad and related conditions |
| 08/21/2008 | CA2676154A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 08/21/2008 | CA2674087A1 6' substituted compounds having 5-ht6 receptor affinity |
| 08/21/2008 | CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 08/20/2008 | EP1958948A1 Pyridazine compound and use thereof |
| 08/20/2008 | EP1958947A1 Inhibitors of phosphodiesterase type 4 |
| 08/20/2008 | EP1958946A1 Pyridazine compound and use thereof |
| 08/20/2008 | EP1957483A1 Novel vinylogous acids derivatives |
| 08/20/2008 | EP1957482A2 Quinazolines useful as modulators of voltage gated ion channels |
| 08/20/2008 | EP1957481A1 Pyrrolidin(thi)ones heterocyclically substituted in 3-position |
| 08/20/2008 | EP1957479A2 1,5-substituted indol-2-yl amide derivatives |
| 08/20/2008 | EP1957478A2 New compounds |
| 08/20/2008 | EP1957477A1 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors |
| 08/20/2008 | EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 08/20/2008 | EP1957459A2 Iminopropene compound and use thereof |
| 08/20/2008 | EP1957457A1 Oxime ester photoinitiators |
| 08/20/2008 | EP1957449A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1957075A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/20/2008 | EP1957058A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 08/20/2008 | EP1692129B1 Keto lactam compounds and use thereof |
| 08/20/2008 | EP1685102A4 Melanocortin receptor agonists |
| 08/20/2008 | EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 08/20/2008 | CN101248156A Novel materials for organic electroluminescent devices |
| 08/20/2008 | CN101248063A Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 08/20/2008 | CN101248061A Hydrates of alkaline-earth salts of irbesartan and the preparation thereof |
| 08/20/2008 | CN101248060A Process for preparing benzimidazole compounds |
| 08/20/2008 | CN101248059A Substituted amide derivatives as protein kinase inhibitors |
| 08/20/2008 | CN101248044A Novel indole compounds |
| 08/20/2008 | CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease |
| 08/20/2008 | CN101245043A Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 08/20/2008 | CN100412066C Compounds and compositions as protein kinase inhibitors |
| 08/19/2008 | US7414071 Such as 5-(3-(2S-(3R-hydroxy-4-(3-trifluoromethyl-phenyl)-butyl)-5-oxo-pyrrolidin-1 -yl)-propyl)-thiophene-2-carboxylic acid; prostaglandin E2 agonists subtypes (EP4); for treatment of (ocular) hypertension, liver failure, and glaucoma |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414066 Anticholesterol agents; antilipemic agents; antiischemic agents; cardiovascular disorders |
| 08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
| 08/19/2008 | US7414064 Pesticides for crops; agriculture, horticulture |
| 08/19/2008 | US7414059 Pyrazolyl and imidazolyl pyrimidines as CRF antagonists |
| 08/19/2008 | US7414058 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 08/19/2008 | US7414057 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
| 08/19/2008 | US7413751 Methods of treatment using a gastric retained losartan dosage |
| 08/19/2008 | CA2488422C Stable solid medicinal ramosetron composition for oral administration |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2294609C Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl)benzenes |
| 08/19/2008 | CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
| 08/19/2008 | CA2200871C Aniline derivatives |
| 08/14/2008 | WO2008098143A2 Antimicrobial compounds and methods of use |
| 08/14/2008 | WO2008097546A2 Compounds that inhibit cholinesterase |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096820A1 Biphenyl derivative |
| 08/14/2008 | WO2008096791A1 Acylguanidine derivative |
| 08/14/2008 | WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates |
| 08/14/2008 | WO2008095999A1 Pyrimidine substituted macrocyclic hcv inhibitors |
| 08/14/2008 | WO2008095823A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands |
| 08/14/2008 | WO2008076805A3 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 08/14/2008 | WO2008076805A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |